GlycoCheck is the leading provider of imaging and measurement software of the endothelial glycocalyx layer. GlycoCheck technology is a complete microvascular imaging solution. It includes the patented GlycoCheck software installed on a dedicated laptop or all-in-one computer. It’s optimized to run the GlycoCheck software application. It comes with a digital intravital microscopic video camera with disposable sanitary tips. The technology measures and monitors changes in the glycocalyx layer non-invasively, accurately, and in real time. The software generates a report and records historical changes in glycocalyx, capillary function, and microvascular blood flow for each patient.
GlycoCheck is currently being used by healthcare practitioners, and for clinical studies in more than 120 hospitals, and universities in Africa, Asia, Australia, China, Europe, Japan, Russia, and the United States. The studies focus on the relationship of the health of the endothelial glycocalyx and its implications for microvascular health in diabetes, kidney disease, cardiovascular disease, vascular dementia, preeclampsia, sepsis, and many other conditions.
GlycoCheck was developed in the Netherlands at the Cardiovascular Research Institute of Maastricht University (CARIM). GlycoCheck has been awarded patents in the U.S., EU, China and Japan, with more patents pending worldwide.
The glycocalyx is perhaps the most important system in the body. The microvascular system provides nutrients to organs and removes waste. Within every blood vessel is a naturally occurring, gel-like lining called the glycocalyx. This gel-like lining helps all blood vessels protect themselves from molecular structures sticking to the vessel wall within the normal range, and plays a decisive role in the early stages of cardiovascular and a number of other diseases that arise when the glycocalyx deteriorates.
